1.14

3.64% 0.04

Pre-market: 1.14

Inovio Pharmaceuticals Inc (INO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Inovio Pharmaceuticals Inc stock is traded at $1.14, with a volume of 1.39M. It is up +3.64% in the last 24 hours and up +0.88% over the past month. Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Previous Close:

$1.10

Open:

$1.11

24h Volume:

1.39M

Relative Volume:

0.87

Market Cap:

$93.01M

Revenue:

$65,300

Net Income/Loss:

$-84.95M

P/E Ratio:

-0.5897

EPS:

-1.9332

Net Cash Flow:

$-88.92M

1W Performance:

-2.56%

1M Performance:

+0.88%

6M Performance:

-53.09%

1Y Performance:

-40.63%

1-Day Range:

$1.10

$1.15

1-Week Range:

$1.10

$1.18

52-Week Range:

$1.03

$2.9789

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Name

Inovio Pharmaceuticals Inc

Sector

Healthcare (1111)

Industry

Biotechnology (622)

Phone

(858) 410-3134

Address

660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA

Employee

112

Twitter

@inoviopharma

Next Earnings Date

2026-05-12

Latest SEC Filings

INO's Discussions on Twitter

Compare INO vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INO Inovio Pharmaceuticals Inc	1.14	89.75M	65,300	-84.95M	-88.92M	-1.9332
VRTX Vertex Pharmaceuticals Inc	429.85	109.34B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	709.21	74.35B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	811.09	50.44B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	297.93	39.78B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.14	33.02B	5.36B	287.73M	924.18M	2.5229

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-09-25	Initiated	Piper Sandler	Overweight
May-14-24	Initiated	Stephens	Overweight
Jan-25-24	Upgrade	Oppenheimer	Perform → Outperform
Nov-09-22	Downgrade	Maxim Group	Buy → Hold
Nov-01-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-19-22	Resumed	RBC Capital Mkts	Sector Perform
May-11-22	Downgrade	Oppenheimer	Outperform → Perform
Jan-21-22	Upgrade	BofA Securities	Underperform → Neutral
Dec-29-21	Resumed	Jefferies	Hold
Sep-10-21	Downgrade	BofA Securities	Neutral → Underperform
Jun-24-21	Initiated	Jefferies	Hold
Mar-23-21	Initiated	BofA Securities	Neutral
Feb-12-21	Initiated	Oppenheimer	Outperform
Nov-17-20	Downgrade	ROTH Capital	Neutral → Sell
Nov-10-20	Upgrade	ROTH Capital	Sell → Neutral
Sep-28-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-28-20	Upgrade	Maxim Group	Hold → Buy
Jul-01-20	Downgrade	Maxim Group	Buy → Hold
Jul-01-20	Downgrade	ROTH Capital	Neutral → Sell
Jun-29-20	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-26-20	Downgrade	Stifel	Buy → Hold
May-21-20	Initiated	The Benchmark Company	Buy
Apr-30-20	Downgrade	ROTH Capital	Buy → Neutral
Mar-13-20	Downgrade	Piper Sandler	Overweight → Neutral
Mar-13-20	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Dec-19-19	Initiated	ROTH Capital	Buy
Feb-15-18	Reiterated	Maxim Group	Buy
Oct-18-17	Initiated	RBC Capital Mkts	Outperform
Sep-06-17	Initiated	Citigroup	Buy
Jun-08-17	Upgrade	Piper Jaffray	Neutral → Overweight
May-24-17	Reiterated	Maxim Group	Buy
Mar-16-17	Upgrade	Maxim Group	Hold → Buy
Mar-16-17	Downgrade	Piper Jaffray	Overweight → Neutral

View All

Inovio Pharmaceuticals Inc Stock (INO) Latest News

May 04, 2026

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

May 04, 2026

INOVIO to Report First Quarter Financial Results on May 13, 2026 - BioSpace

May 04, 2026

May 01, 2026

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

May 01, 2026

INOVIO to discuss Q1 results and business update in May 13 webcast - Stock Titan

May 01, 2026

INO Stock Price, Quote & Chart | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill

May 01, 2026

Apr 29, 2026

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Sees Significant Growth in Short Interest - MarketBeat

Apr 29, 2026

Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 29, 2026

Apr 28, 2026

Inovio Pharmaceuticals (INO) price target decreased by 12.21% to 6.90 - MSN

Apr 28, 2026

Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Apr 28, 2026

Apr 27, 2026